Whether thresholds calibrated to an individual detect real change more accurately than a fixed published cut-off, tested against thresholds committed before any data is collected.
01
Conformal intervals from a participant's own history achieve realised coverage within ±0.03 of the stated 0.90.
Within-person thresholds outperform the published fixed MDC of 5.0 kg on the same observations, measured by F1.
Participants whose measurements are genuinely stable are flagged as changed at a rate not exceeding 0.15.
02
Per-participant thresholds are derived from their own baseline scatter during weeks 3–4 and locked at the same moment, before any verdict is shown to anyone.
03
Why
If a participant is told what the system thinks before their baseline is set, the threshold that follows is estimated from a sample the system shaped. Nothing in a conventional analysis would reveal it.
Schedule
Weeks 1–2 enrolment and instrument training. Weeks 3–4 baseline, no verdicts. Weeks 5–20 the study proper. Weeks 21–22 analysis against the locked registration.
04
Against the stated 0.90, tolerance ±0.03. The primary endpoint; everything else rests on it.
Among participants with no detectable trend.
Scored by F1, never PPV alone. A near-silent rule scores high PPV by default: in simulation a fixed cut-off reached 100% PPV while catching 3 of 69 real changes.
Proportion of verdicts that changed what a participant did, self-reported at the following occasion.
MAE and coverage on the 20% of occasions no estimator ever saw.
05
If realised coverage falls outside 0.85–0.95 at 139 occasions, the study stops and the cause is diagnosed. Continuing to 385 to obtain a tighter estimate of a broken number wastes 25 people's time.
If the fixed cut-off leads on F1 at the interim gate and the comparison is not degenerate, the study completes but H2 is reported as rejected. Personalisation not earning its complexity is a finding.
If the registration hash fails verification, every result computed against it is void and the study restarts under a new registration.
06
A randomised trial already found the null (β = 0.06, 95% CI −1.33 to 1.44, P = 0.94). No genomic endpoint appears here.
The output is change from a participant's own baseline with a stated false-alarm rate.
Coverage on one measurand in a self-selected group of 25 is not coverage in general.
Participants are not assigned to interventions.